Using the PEG framework with analyst consensus forward EPS growth of 25.0% plus 0.3% dividend yield, Revvity, Inc. has a fair value of $135.02 based on NTM EPS (FY2026) of $5.40. The current PEG ratio is 0.52.
PEG < 1 = bargain, 1–1.5 = fair, > 2 = expensive.
Growth above 25% is capped — hypergrowth may not be sustainable long-term.
| EPS Growth RateForward | 30.6% |
| Dividend Yield | +0.3% |
| Adjusted Growth (clamped 8–25%)Clamped | 25.0% |
| Fair P/E | 25.0x |
| NTM EPS (FY2026) | $5.40 |
| Fair Value | $135.02 |
| Period | EPS Est. | Growth | Analysts |
|---|---|---|---|
| FY2025 (actual) | $2.08 | — | — |
| FY2026E | $5.40 | +159.7% | 13 |
| FY2027E | $5.98 | +10.7% | 13 |
| FY2028E | $6.53 | +9.2% | 9 |
| FY2029E | $7.16 | +9.6% | 8 |
| FY2030E | $7.91 | +10.6% | 4 |
5Y Forward EPS CAGR: 30.6%
The PEG Fair Value uses the Price/Earnings-to-Growth framework. A stock is fairly valued when its P/E ratio equals its earnings growth rate (PEG = 1.0). This model adds dividend yield to the growth rate per the original PEGY formula.
Growth rate priority: analyst consensus forward EPS CAGR (when ≥ 3 analysts cover the stock), falling back to historical EPS CAGR. Using EPS rather than net income avoids distortion from share buybacks. The growth rate is clamped between 8% and 25% — below 8% would undervalue stable earners, while above 25% would overvalue unsustainable spikes.
| Year | Net Income | EPS | YoY |
|---|
| FY2021 | $943.2M | $8.08 | — |
| FY2022 | $569.2M | $4.50 | -44.3% |
| FY2023 | $-118.4M | $-0.95 | -121.1% |
| FY2024 | $295.8M | $2.41 | — |
| FY2025 | $241.7M | $2.08 | -13.7% |
4Y Historical EPS CAGR: -28.8%